home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
  HUM-MOLGEN -> Genetic News | search  

In vitro reconstruction of skin from cancer-prone disease

  July, 12 2001 7:40
your information resource in human molecular genetics
Xeroderma Pigmentosum (XP) is a rare hereditary disease characterized by increased sensitivity to sunlight and high incidence of skin cancers. These phenotypical features could be attributed to a deficiency in the repair of UV-light-induced DNA lesions. Thereafter, the proteins mutated in either of the 7 XP complementation groups (XPA-XPG) were cloned and shown to be directly involved in a DNA repair pathway, namely the Nucleotide Excision Repair pathway.

Now, using cultured cells issued from XP patients, researchers have developed a skin model for XP. As reported in the last week's issue of PNAS (Bernerd et al., Proc Natl Acad Sci U S A 2001 Jul 3; 98(14):7817-7822), the in vitro reconstituted XP skin presents both a high proliferation rate of keratinocytes and epidermal invasion within dermal skin parts which are characteristic of early steps of skin neoplasia. Thus, this in vitro skin model will not only open new research opportunities for XP therapy, but could also represent a powerful tool for photoaging and photocarcinogenesis research.


Thierry Magnaldo
7, rue Guy Môquet
94801 Villejuif, France
e-mail magnaldo@infobiogen.fr

Message posted by: Ulrike Sattler

print this article mail this article
Bookmark and Share this page (what is this?)

Social bookmarking allows users to save and categorise a personal collection of bookmarks and share them with others. This is different to using your own browser bookmarks which are available using the menus within your web browser.

Use the links below to share this article on the social bookmarking site of your choice.

Read more about social bookmarking at Wikipedia - Social Bookmarking

Latest News
Variants Associated with Pediatric Allergic Disorder

Mutations in PHF6 Found in T-Cell Leukemia

Genetic Risk Variant for Urinary Bladder Cancer

Antibody Has Therapeutic Effect on Mice with ALS

Regulating P53 Activity in Cancer Cells

Anti-RNA Therapy Counters Breast Cancer Spread

Mitochondrial DNA Diversity

The Power of RNA Sequencing

‘Pro-Ageing' Therapy for Cancer?

Niche Genetics Influence Leukaemia

Molecular Biology: Clinical Promise for RNA Interference

Chemoprevention Cocktail for Colon Cancer

more news ...

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2017 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.